Covid-19 is self-destructive too! Study shows how virus-infected cells can explode causing damage to lungs, internal organsSome Covid infected cells can 'explode' causing serious damage of the lungs and other internal organs.
17 May, 2022, 07.19 PM IST
Stempeutics gets DCGI nod for Phase 3 clinical trial on its product for treating COVID patientsStempeucel exhibits potent immuno-modulatory and anti-inflammatory properties which could help in reducing the inflammation caused due to t...
18 Jan, 2022, 03.09 PM IST
Indian-American doctor identifies possible COVID-19 treatmentThe researchers detailed how the inflammatory cell death signaling pathway worked, which led to potential therapies to disrupt the process.
21 Nov, 2020, 09.59 AM IST
Simple laboratory tests are playing an important role in risk stratification of Covid-19Patients with severe Covid-19, are prone to a cytokine storm, that can be fatal. A cytokine storm in an uncontrollable secretion of pro-inf...
17 Nov, 2020, 03.37 PM IST
Arthritis drug may improve COVID-19 survival among elderly patients, says studyIn the research, published in the journal Science Advances, 83 patients with a median age of 81 and all suffering from moderate to severe C...
16 Nov, 2020, 04.27 PM IST
Steroid treatment should be reserved for sickest COVID-19 patients, say scientistsScientists, including those from St. Jude Children's Research Hospital in the US, assessed the levels of the immune system protein cytokine...
15 Nov, 2020, 01.57 PM IST
Some patients suffering from severe conditions may not develop immunity to coronavirusHigh levels of a molecule in Covid patients may prevent them from developing immunity.
20 Aug, 2020, 06.01 PM IST
Viral infection or coronavirus? How Covid-19 smell, taste loss differs from common cold, decodedSmell loss is much more profound in the Covid-19 patents, and they are less able to identify smells.
19 Aug, 2020, 04.31 PM IST
We are going to do phase-4 trial of psoriasis drug on Covid patients: Kiran Mazumdar ShawThe Drug Controller gave Biocon an restricted emergency use authorisation to try out and continue to treat Covid-19 patients and then do a ...
17 Jul, 2020, 03.57 PM IST
Biocon gets DCGI nod to use Itolizumab in moderate to severe Covid-19 patientsBiocon said the approval is based on the results from the successful conclusion of a randomized, controlled clinical trial at multiple hosp...
11 Jul, 2020, 05.12 PM IST
Scientists discover small proteins which may reduce inflammation caused by COVID-19The therapeutic, described in the journal Cell Reports, is called TAT CARMIL1, and is actually a combination of two naturally occurring sma...
05 Jul, 2020, 02.40 PM IST
Blood test can help suggest which Covid-19 patient needs a ventilator, determine the role of diabetesThe researchers tested blood samples taken from the patients within 48 hours of diagnosis.
04 Jul, 2020, 06.03 PM IST
Biosimilar drugs can help us reach $1 billion target soon: Christiane Hamacher, CEO, Biocon BiologicsIt is all about reaching our $1billion revenue target by FY22 and to reach 5 million patients by end of 2022, says Christiane Hamacher.
16 Jun, 2020, 11.03 AM IST
Biocon gets DCGI nod for device to treat critical COVID-19 patientsThe company has been granted licence for emergency use of CytoSorb, an extracorporeal blood purification device CytoSorb to reduce pro-infl...
27 May, 2020, 12.57 PM IST
How COVID-19 can damage your heartSimply put, when a person is infected by the novel coronavirus his or her immune system tries to fight back. Too many cytokines — small pro...
17 May, 2020, 10.18 AM IST
Biocon says use of Itolizumab in COVID-19 treatment encouragingBiocon has witnessed encouraging results in the use of its novel biologic Itolizumab for treating some Covid-19 related conditions, the pha...
16 May, 2020, 09.11 AM IST
Treating Covid-19: Clinical trials using arthritis drug get nod“The CDSCO (Central Drugs Standard Control Organisation) has approved a vital randomised controlled trial on Covid-19 treatment with a biol...
12 May, 2020, 12.28 PM IST